Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Investors acquired 28,801 call options on the company. This is an increase of 61% compared to the typical daily volume of 17,846 call options.
Insider Buying and Selling at Teladoc Health
In other news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.58% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Teladoc Health
Institutional investors have recently bought and sold shares of the stock. Golden State Wealth Management LLC lifted its holdings in Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the period. National Bank of Canada FI increased its holdings in shares of Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares during the period. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC increased its holdings in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the period. Finally, SVB Wealth LLC acquired a new position in shares of Teladoc Health in the 1st quarter valued at about $37,000. Institutional investors and hedge funds own 76.82% of the company's stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on TDOC shares. Canaccord Genuity Group dropped their price objective on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Citigroup dropped their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research note on Friday, April 25th. Truist Financial dropped their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Finally, Bank of America dropped their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $9.60.
Check Out Our Latest Research Report on TDOC
Teladoc Health Stock Performance
Shares of TDOC traded down $0.06 during midday trading on Friday, hitting $6.92. 6,253,823 shares of the stock traded hands, compared to its average volume of 6,265,428. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The firm has a market capitalization of $1.21 billion, a PE ratio of -1.20 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The business's 50 day moving average price is $7.26 and its two-hundred day moving average price is $9.20.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities research analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
